Assignee
NEOTX THERAPEUTICS LTD
IL·3 granted patents·5 pending applications·5 citations·filing 2017–2023
Top patents by PatentIndex Score
8 records- 0180US10314910B2Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapyNEOTX THERAPEUTICS LTD·Filed 2017·Granted Jun 11, 2019·4 cites·8 claims
- 0276US11202829B2Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapyNEOTX THERAPEUTICS LTD·Filed 2019·Granted Dec 21, 2021·1 cites·13 claims
- 0374US2024100156A1Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapyNEOTX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0467US11607452B2Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapyNEOTX THERAPEUTICS LTD·Filed 2019·Granted Mar 21, 2023·0 cites·13 claims
- 0554US2024197784A1Methods and compositions for treating glioblastomaNEOTX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0651US2023285588A1Superantigen conjugate for use in methods and compositions for treating cancerNEOTX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0749US2023085724A1Methods and compositions for treating cancer with immune cellsNEOTX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0846US2022213194A1Cancer treatmentNEOTX THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEOTX THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →